Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of the full human anti-tetanus toxin monoclonal antibody SNA02-48 injection and compare the Tetanus-antibody levels and safety of SNA02-48 with human tetanus immunoglobulin (HTIG) in Chinese adult participants.
Epistemonikos ID: 70c5f5dda5974357116bf62a611381d23b062b4a
First added on: Apr 24, 2025